India’s pharmacies are the last mile in a powerful global supply chain—but informal credit systems are holding them back. AI-driven credit assessment could be the key to unlocking resilience and reach ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

The linearized power flow (PF) model is mainly used to make the optimal power flow (OPF) problem convex. However, existing data-driven linear PF models are not applicable for OPF calculation since the ...

Tariffs and Middle East turmoil are spooking European companies and the investors weighing their initial public offerings ...

OptimizeRx OPRX kicked off 2025 with strong momentum, delivering 11% year-over-year revenue growth to $21.9 million and ...

Four SWAN stocks, Realty Income, Alphabet, Globe Life, and Thermo Fisher, offer low-risk value and growth potential. See why ...

GEA Group maintains a conservative balance sheet, helping to shield shareholders from the inherent volatility in capital equipment spending in GEA’s various end markets. The balance sheet sits in a ...

Process validation is often viewed as a costly regulatory formality. However, it is actually a strategic investment that, ...

OptimizeRx OPRX, a digital health platform that connects pharmaceutical companies with healthcare providers and patients, ...

Thermo Fisher's strong economic moat, slowing growth, and fair valuation. Valuation is reasonable, trading near decade-low ...

Frost & Sullivan commends Novotech for setting a high standard in competitive strategy, execution, and market responsiveness.

Hospitals nationwide are grappling with high patient volumes, staffing shortages and inefficient capacity management — all while being asked to deliver timely, high-quality care. During a recent ...